Moving one step forward, adoptively transferred CD70-expressing immature DCs could prime CD8+T-cells, by CD27, to become tumor-eradicating cytolytic effectors and memory cells with a capacity for robust secondary expansion, independently of CD4+T-helpers. The gene discussed is CD8A; the disease is neoplasm.